<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-ETH-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Ethiopia: Targeted country assistance</narrative>
   <narrative xml:lang="FR">&#xC9;thiopie (l&apos;): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Acasus</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">John Snow, Inc.</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.21107.35" role="4">
   <narrative xml:lang="EN">Johns Hopkins University</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Ethiopia</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ET" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="ET" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Addis Ababa</narrative>
   </name>
   <administrative code="ET" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>9.02497 38.74689</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">4432462</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">5872395</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">4906652</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1161687</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">87979</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="ETHPEF-TCA-ACASUS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">692704</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CCRDA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">424607</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">27000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">579600</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">108789</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JHU2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">172399</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JOHN SNOW2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">195516</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">444153</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">13677</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">954615</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">819401</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-ACASUS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">876340</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CCRDA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">447910</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">282936</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">383593</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JHU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JOHN SNOW2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">219190</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">109500</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">945887</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">34190</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1243469</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1329381</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-ACASUS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">907240</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CCRDA2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">215740</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">397552</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">365928</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JOHN SNOW2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">203651</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">218999</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">689744</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">50726</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">953191</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">903882</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-ACASUS2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">101080</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">68851</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">527480</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">238305</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">225971</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2023">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">87979</value>
   <description>
    <narrative xml:lang="EN">2023 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001020">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">133912</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001185">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">96517</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006978">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">261840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-41782</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">41782</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001263">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000329">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-13"></transaction-date>
   <value currency="USD" value-date="2020-02-13">41782</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000440">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-19"></transaction-date>
   <value currency="USD" value-date="2020-02-19">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000870">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">26596</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001088">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-24"></transaction-date>
   <value currency="USD" value-date="2020-03-24">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002509">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">15877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002508">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">173880</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003780">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-16"></transaction-date>
   <value currency="USD" value-date="2020-09-16">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003820">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-21"></transaction-date>
   <value currency="USD" value-date="2020-09-21">4843</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-157702</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">157702</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-08"></transaction-date>
   <value currency="USD" value-date="2020-12-08">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005409">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-17"></transaction-date>
   <value currency="USD" value-date="2020-12-17">6319</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-185144</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">185144</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001335">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-29"></transaction-date>
   <value currency="USD" value-date="2021-03-29">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001380">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">13155</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003036">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">173880</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003065">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-14"></transaction-date>
   <value currency="USD" value-date="2021-07-14">5605</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003730">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">95500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004515">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-21"></transaction-date>
   <value currency="USD" value-date="2021-09-21">47750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004905">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-05"></transaction-date>
   <value currency="USD" value-date="2021-10-05">120840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005147">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-12"></transaction-date>
   <value currency="USD" value-date="2021-10-12">47750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-18"></transaction-date>
   <value currency="USD" value-date="2021-10-18">66868</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006774">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">120840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006950">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">5431</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001016">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">244742</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001181">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-27805</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001315">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-163303</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003836">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">126672</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">33715</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-33715</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000340">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-17"></transaction-date>
   <value currency="USD" value-date="2020-02-17">210586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003100">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">27416</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-210586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">210586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-46283</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">46283</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000296">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-28"></transaction-date>
   <value currency="USD" value-date="2021-01-28">43607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-2990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">2990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001179">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">65951</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002763">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-16"></transaction-date>
   <value currency="USD" value-date="2021-06-16">68001</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003333">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-15"></transaction-date>
   <value currency="USD" value-date="2021-07-15">32243</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004977">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-15"></transaction-date>
   <value currency="USD" value-date="2021-11-15">43597</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">131064</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-3293</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">3293</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001955">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-10"></transaction-date>
   <value currency="USD" value-date="2022-03-10">3992</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001955">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-10"></transaction-date>
   <value currency="USD" value-date="2022-03-10">6283</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000901">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">20250</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">6750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000902">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">434700</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-02"></transaction-date>
   <value currency="USD" value-date="2019-12-02">144900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">282936</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001204">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">94312</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">303240</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000982">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-2900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001142">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">71661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001286">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-40028</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000849">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-12"></transaction-date>
   <value currency="USD" value-date="2019-12-12">49950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000974">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">30105</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003534">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">22380</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005050">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">45254</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005608">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">9699</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-17725</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">17725</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000584">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="USD" value-date="2021-02-11">67140</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001232">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">22811</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001906">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">45623</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003278">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">521</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002484">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">61613</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005328">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-20"></transaction-date>
   <value currency="USD" value-date="2021-10-20">110774</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001017">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">233032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001182">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-65027</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001316">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-65027</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006979">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">69421</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001018">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">50562</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001183">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">71757</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001317">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-117397</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003837">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">81085</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">80877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-80877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000221">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000923">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">20501</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002771">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">47885</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004759">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">28030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15461</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-18677</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-3397</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15461</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">18677</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">3397</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000769">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-25"></transaction-date>
   <value currency="USD" value-date="2021-02-25">28030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001942">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">162</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002013">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">62072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003822">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-12"></transaction-date>
   <value currency="USD" value-date="2021-08-12">47152</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005171">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-12"></transaction-date>
   <value currency="USD" value-date="2021-10-12">28030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006815">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">2861</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">45896</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000693">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">45896</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003498">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">46119</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006746">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">71718</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000531">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-26"></transaction-date>
   <value currency="USD" value-date="2022-01-26">5504</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001019">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-93078</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001184">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">172936</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-172936</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006980">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">290592</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">86537</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001263">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">130102</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">30000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-30000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000977">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-19"></transaction-date>
   <value currency="USD" value-date="2020-03-19">18145</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">60877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002723">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">148072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">99181</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-43349</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">43349</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000311">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-02"></transaction-date>
   <value currency="USD" value-date="2021-02-02">103828</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000700">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">143756</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000163">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">30178</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-86428</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">86428</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001523">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">51458</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003010">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">103366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003108">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">59762</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003010">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">74060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-74060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">74060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001957">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-10"></transaction-date>
   <value currency="USD" value-date="2022-03-10">175414</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">12101</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-816</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">16190</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-14726</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">14726</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">1800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">4200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000903">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">715961</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">238654</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">714827</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-238654</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">238654</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">289767</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">238276</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">714916</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000904">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">702344</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">117057</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">677910</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-117057</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">117057</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">534413</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">677912</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ethiopia-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ethiopia-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ethiopia-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-ETH" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 months of the measles 5 dose RCT implemented in study sites (across 60 woredas). Finalize field protocol for the endline survey.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the implementation period, and carry out the endline survey for a study to examine the impact of the use of a 5 dose measles vaccine vial on measles coverage. CDC has been working with Ethiopia MoH, JSI, WHO, UNICEF, EPHI and RHBs to implement a randomized control study to document and measure the impact of reducing the measles vaccine vial size from a 10-dose vial to a 5-dose vial. The baseline is complete, and the study started implementation mid-December 2020 and will continue for 1 year. We are implementing 3 arms in the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and will measure the impact on immunization coverage pre and post implementation. The findings from this study will be highly relevant for Ethiopia and other countries considering changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">10 months of implementation are now complete and are on track for completion of the implementation period in March-April 2022. There have been some health facilities that are noted to be impacted by security issues, which have hampered implementation of the intervention, and all health services, broadly speaking. These impacts will be accounted for when analyzing the results from this study. The endline survey field protocol is currently under revision, with plan for the endline survey still in place for March-April 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Demand creation for MCV2 and RI; data triangulation for programatic use around MCV2 and RI; recommendations for reporting/recording quality improvements</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical assistance in support of increasing MCV2 uptake in Ethiopia in Oromia Region, including
 a) programmatic support for strategies to increase uptake;
 b) support for increasing the quality of recording/reporting of vaccines doses delivered in 2YL;
 c) assessing strategies for improving defaulter tracing and, use of MCV2 as an opportunity for catch-up of children who missed their measles vaccination during the first year of life; 
d) communications messaging to increase awareness and demand for MCV2; 
e) capacity building for data quality assurance, analysis and triangulation of MCV1 &amp; MCV2 data, measles surveillance data and outbreak data at the district level); 
f) support field implementation of operations research on aforementioned topics">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">An ongoing MCV2 barriers assessment is nearing completion and will provide important information that will guide the tailoring of this technical assistance around increasing MCV2 uptake in Oromia Region. The assessment had minor delays which have resulted in the minor delays with this work.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Carry out a dissemination workshop on the barriers to MCV2 uptake in Oromia Region (across 18 woredas); supportive supervision in priority Zones focusing on MCV2; systematically assess the defaulter tracing mechanisms in the Region broadly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical assistance in support of increasing MCV2 uptake in Ethiopia in Oromia Region, including
 a) programmatic support for strategies to increase uptake;
 b) support for increasing the quality of recording/reporting of vaccines doses delivered in 2YL;
 c) assessing strategies for improving defaulter tracing and, use of MCV2 as an opportunity for catch-up of children who missed their measles vaccination during the first year of life; 
d) communications messaging to increase awareness and demand for MCV2; 
e) capacity building for data quality assurance, analysis and triangulation of MCV1 &amp; MCV2 data, measles surveillance data and outbreak data at the district level); 
f) support field implementation of operations research on aforementioned topics">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The dissemination workshop is delayed and we are awaiting the final report of the MCV2 barriers study findings. However, planning is underway to hold this workshop after the general election in August/September 2021. Supportive supervision to priority Zones focusing on MCV2 is ongoing as is the systematic assessment of defaulter tracing mechanisms. For the latter, a new wooden design of tickler boxes is under production to implement a more systematic system in pilot areas.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical assistance in support of increasing MCV2 uptake in Ethiopia in Oromia Region, including a) programmatic support for strategies to increase uptake; b) support for increasing the quality of recording/reporting of vaccines doses delivered in 2YL; c) assessing strategies for improving defaulter tracing and, use of MCV2 as an opportunity for catch-up of children who missed their measles vaccination during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation of MCV1 &amp; MCV2 data, measles surveillance data and outbreak data at the district level); f) support field implementation of operations research on aforementioned topics">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The workshop regarding the findings is tentatively scheduled for January 2022. Supportive supervision within the priority zones continues. For the systematic assessment of defaulter tracing mechanisms, a detailed protocol has been developed by the CDCF consultant in consultation with the CDC team and the systematic assessment will be carried out in the new calendar year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">6 months of the measles 5 dose RCT implemention completed in study sites (across 60 woredas). Interim report on progress at half way point of implementtaion.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the implementation period, and carry out the endline survey for a study to examine the impact of the use of a 5 dose measles vaccine vial on measles coverage. CDC has been working with Ethiopia MoH, JSI, WHO, UNICEF, EPHI and RHBs to implement a randomized control study to document and measure the impact of reducing the measles vaccine vial size from a 10-dose vial to a 5-dose vial. The baseline is complete, and the study started implementation mid-December 2020 and will continue for 1 year. We are implementing 3 arms in the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and will measure the impact on immunization coverage pre and post implementation. The findings from this study will be highly relevant for Ethiopia and other countries considering changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The measles 5 dose study reached 6 months of RCT implementation mid-June 2021. Reports are available, and a full mid-term assessment of where the team is in terms of the field activities is being planned for after the General Election.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete of implementation period (runs in total for 16 months), and reporting on status. Carry out endline survey.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature. CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial. IRB approval has already been optained and baseline data collection is planned to begin Q4 2019. We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">10 months of implementation are now complete and are on track to carry out the remaining implementation. The endline survey remains scheduled as planned in March-April 2022 and current survey details are being discussed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature.   CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial.  IRB approval has already been optained and baseline data collection is planned to begin Q4 2019.  We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">6 months of implementation is now complete, and on track to carry out the remaining implementation. The endline survey will be carried out in March-April 2022 given where the team is with the current stage of the implementation of the measles 5 dose study.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature.   CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial.  IRB approval has already been optained and baseline data collection is planned to begin Q4 2019.  We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">6 months of implementation is now complete, and on track to carry out the remaining implementation. The endline survey will be carried out in March-April 2022 given where the team is with the current stage of the implementation of the measles 5 dose study.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete a further 6 months of the implementation phase initiated in selected zones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature. CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial. IRB approval has already been optained and baseline data collection is planned to begin Q4 2019. We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">6 months of implementation is now complete, and on track to carry out the remaining implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% zones, woredas and HFs improve data as measured by DQR and data triangulations (baseline ISS, DQS)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Because of shortage of budget the triangulation workshop was not conducted in the reporting period ,however JRF data and immunization coverage estimate prepared and submitted for AFRO</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Because of shortage of budget the triangulation workshop was not conducted in the reporting period ,however JRF data and immunization coverage estimate prepared and submitted for AFRO</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO supported technically FMOH and other partners who are working on immunization data to estimate the national and subnational immunization coverage estimate using data triangulation guideline</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identified bottlenecks and gaps in RI service delivery by private health facilities. Based on bottleneck assessment action plan developed and shared with MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify bottlenecks and gaps in RI service delivery by private health facilities and based on the need assessment provide mitigating annual plan to improve the quality of the service being provided.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Assessment carried out and gaps identified.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify bottlenecks and gaps in RI service delivery by private health facilities and based on the need assessment provide mitigating annual plan to improve the quality of the service being provided.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Assessment carried out and gaps identified.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Readiness assessment for HPV Implementation for 2nd cohort implementation conducted, recommendations for mitigating any bottlenecks or challenges made</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted preliminary supportive supervision and report the findings to the FMOH on different preparatory activities of the HPV and other NVI introduction, including support to any necessary analysis of data">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Assessment successfully conducted, integrated with assessment for 3rd cohort first vaccination. See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted preliminary supportive supervision and report the findings to the FMOH on different preparatory activities of the HPV and other NVI introduction, including support to any necessary analysis of data">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Assessment successfully conducted, integrated with assessment for 3rd cohort first vaccination. See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strengthened coordination contributed to timely HPV implementation as per plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate partners and different technical working group meetings in preparation and timely distribution of training manuals, guidelines, job-aids, and communication tools on HPV">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">CHAI supported the MOH to adapt the work plan to fit with updated education timelines (due to COVID disruptions) and to adjust to the ongoing conflict in some regions. CHAI also supported the FMOH to update work plans related to engagement and communication in light of special policy for education due to the COVID-19 circumstance and potential hesitancy related to the COVID-19 vaccine rollout.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate partners and different technical working group meetings in preparation and timely distribution of training manuals, guidelines, job-aids, and communication tools on HPV">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">CHAI supported the MOH to adapt the work plan to fit with updated education timelines (due to COVID disruptions) and to adjust to the ongoing conflict in some regions. CHAI also supported the FMOH to update work plans related to engagement and communication in light of special policy for education due to the COVID-19 circumstance and potential hesitancy related to the COVID-19 vaccine rollout.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?HPV implementation regularly monitored?and reviewed, and actions taken</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the FMOH to implement coordinated and cascaded post introduction monitoring activities such as supportive supervisions, review meetings, regular reporting of the HPV immunisation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Implementation regularly reviewed with MOH, including critical post launch activities and performance checks integrated into supportive supervisions, review meetings, etc to confirm HPV vaccination performance. See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the FMOH to implement coordinated and cascaded post introduction monitoring activities such as supportive supervisions, review meetings, regular reporting of the HPV immunisation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Implementation regularly reviewed with MOH, including critical post launch activities and performance checks integrated into supportive supervisions, review meetings, etc to confirm HPV vaccination performance. See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Guideline developed and validated by MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Guideline development for engaging private facilities in EPI services">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Initial guidance has been developed, however CHAI is proposing additional work could be carried forward. See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Guideline development for engaging private facilities in EPI services">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Initial guidance has been developed, however CHAI is proposing additional work could be carried forward. See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regular SS and Mentoring to selected Private HFs conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct continuous supportive supervision, monitoring and evaluation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Ongoing, incorporating lessons from initial assessment. See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Global PIE recommendations integrated into H2 2021 activities for subsequent cohorts?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mitigations identified are implemented on a timely manner for H2 2021 vaccination cohort, with sustainability plans defined">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">PIE activities are delayed, however post launch and supportive supervision data has been integrated and the PIE data will be integrated into H2 activities and future cohorts. Please also see narrative report attached to &quot;strengthened coordination contributed to timely HPV implementation as per plan&quot; milestone.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mitigations identified are implemented on a timely manner for H2 2021 vaccination cohort, with sustainability plans defined">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">PIE activities are delayed, however post launch and supportive supervision data has been integrated and the PIE data will be integrated into H2 activities and future cohorts. Please also see narrative report attached to &quot;strengthened coordination contributed to timely HPV implementation as per plan&quot; milestone.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NVI decision making best practices and Lessons learned identified and documented for subsequent reviews</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the documentation of lessons learnt to be shared as best practices from the introduction of new vaccine">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Please also see narrative report attached to &quot;strengthened coordination contributed to timely HPV implementation as per plan&quot; milestone. CHAI has been actively working with MOH to review NVI (HPV and other) best practices and lesson learnt to develop recommendation for future NVIs in the Ethiopian context.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the documentation of lessons learnt to be shared as best practices from the introduction of new vaccine">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Please also see narrative report attached to &quot;strengthened coordination contributed to timely HPV implementation as per plan&quot; milestone. CHAI has been actively working with MOH to review NVI (HPV and other) best practices and lesson learnt to develop recommendation for future NVIs in the Ethiopian context.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Detailed HPV Micro plan developed and utilised for new HPV cohort administration</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop detailed HPV Vaccine introduction plan/micro-plan with timelines and clear responsibilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop detailed HPV Vaccine introduction plan/micro-plan with timelines and clear responsibilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Subnational MP developed and utilised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize sub-national microplanning ?exercise and collect and compile MPs at the central level">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize sub-national microplanning ?exercise and collect and compile MPs at the central level">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?All preparation, implementation and monitoring of the NVI/HPV activities implemented as per the chronogram developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EPI taskforce and technical working groups (EPI Logistics, Communication and monitoring and evaluation) in planning adequate Cold Chain and Supply, developing appropriate communication materials and monitoring of the planned activities implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EPI taskforce and technical working groups (EPI Logistics, Communication and monitoring and evaluation) in planning adequate Cold Chain and Supply, developing appropriate communication materials and monitoring of the planned activities implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mitigations identified are implemented on a timely manner for H2 2021 vaccination cohort, with sustainability plans defined</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review and analyze monitoring and implementation data to identify challenges and take corrective actions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;strengthen coordination contributed to timely HPV implementation as per plan&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review and analyze monitoring and implementation data to identify challenges and take corrective actions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to &quot;strengthen coordination contributed to timely HPV implementation as per plan&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">quarterly SS and Mentoring to selected Private HFs conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct continuous supportive supervision, monitoring and evaluation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct continuous supportive supervision, monitoring and evaluation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Experience sharing and sensitisation workshop conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Experience sharing with government health facilities with long time experience of RI service delivery will also be conducted.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Experience sharing with government health facilities with long time experience of RI service delivery will also be conducted.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50 Private HFs EPI Focal/Vaccinators trained on standard IIP and EVMA training</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building activities by providing the required training such as Vaccine management, IIP, MLM, preventive maintenance, including on job training.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building activities by providing the required training such as Vaccine management, IIP, MLM, preventive maintenance, including on job training.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recommendations shared and action plan developed with FMOH for optimizing RI service at private HFs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support coordination of optimisation of the necessary service delivery components in private health facilities (such as make sure they are using optimal cold chain equipment, temperature monitoring devices, injection safety measures, proper recording and reporting system, effective vaccine management etc.).">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support coordination of optimisation of the necessary service delivery components in private health facilities (such as make sure they are using optimal cold chain equipment, temperature monitoring devices, injection safety measures, proper recording and reporting system, effective vaccine management etc.).">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Any bottlenecks w/ novel routine RI data reporting system identified, and mitigation recommendations developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support establishment of routine reporting system">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support establishment of routine reporting system">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual Review meeting conducted, challenges identified, and action plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate review meeting to evaluate the outcomes as per the plan and document the lesson learnt and share.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate review meeting to evaluate the outcomes as per the plan and document the lesson learnt and share.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate review meeting to evaluate the outcomes as per the plan and document the lesson learnt and share.">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regular Support to AARHB provided</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to Addis Ababa regional Health Bureau in strengthening optimizing, monitoring and capacity building activities to private routine immunisation delivering health facilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Support to AARHB has been provided via supportive supervisions, best practices exchanges with strong performing public HFs to private. See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to Addis Ababa regional Health Bureau in strengthening optimizing, monitoring and capacity building activities to private routine immunisation delivering health facilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Support to AARHB has been provided via supportive supervisions, best practices exchanges with strong performing public HFs to private. See report attached to milestone &quot;Identified bottlenecks and gaps in RI service delivery by private health facilities&quot;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical Support provided for MoH on NVI at all levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide all rounded TA to other NVIs in pipeline">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Technical support is ongoing -- it has been provided for the wider NVI prioritization conversation. In the last reporting period the focus has been on Hep B BD and Covid NVI (the latter of which has moved to Covax TA since March 2021). Please also see narrative report attached to &quot;strengthened coordination contributed to timely HPV implementation as per plan&quot; milestone.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide all rounded TA to other NVIs in pipeline">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Technical support is ongoing -- it has been provided for the wider NVI prioritization conversation. In the last reporting period the focus has been on Hep B BD and Covid NVI (the latter of which has moved to Covax TA since March 2021). Please also see narrative report attached to &quot;strengthened coordination contributed to timely HPV implementation as per plan&quot; milestone.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV data captured, compiled and report narrated and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Timely Collection and Compilation of reports at National and subnational level and develop comprehensive technical report">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Data compiled and comprehensive report shared with MOH. See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Timely Collection and Compilation of reports at National and subnational level and develop comprehensive technical report">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Data compiled and comprehensive report shared with MOH. See report attached to &quot;Strengthened coordination contributed to timely HPV implementation as per plan milestone&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Funding received, a) IRB protocol developed and submitted for review; b-e) reference materials gathered, best practices materials gathered from other countries, and locally to strengthen implementation; f) continue work started last TCA cycle</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">IRB protocol was developed and approved by the scientific and ethical review committee of the Oromia Regional Health Bureau. Field work is completed, analysis and write up are now ongoing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">a) Final report on study findings and dissemination through various fourms; b, c, e) Materials pilot tested and status reported; d) recommendations on approaches aimed at increasing awareness and demand for MCV2, with focus subnationally in Oromia Region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The MCV2 barriers assessment has completed all the field work and the study findings are currently being compiled into a final report. There are two sections to the work that are currently undergoing analysis: a) the quantitative survey across 18 districts of healthcare workers, caregivers and EPI focal persons in the Region (in total &gt;1,600 individuals were interviewed), and b) a series of detailed qualitative focus group discussions (&gt;80), and in-depth interviews (&gt; 40) with healthcare workers, caregivers, EPI focals and community leaders across 10 districts. Both will be combined for one overall comprehensive report on the barriers to MCV2 across the Oromia Region. Increasing the awareness on the demand for MCV2 is complete through radio messaging in the local language across the Region, and also ongoing demand generation activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The MCV2 barriers assessment has completed all the field work and the study findings are currently being compiled into a final report. There are two sections to the work that are currently undergoing analysis: a) the quantitative survey across 18 districts of healthcare workers, caregivers and EPI focal persons in the Region (in total &gt;1,600 individuals were interviewed), and b) a series of detailed qualitative focus group discussions (&gt;80), and in-depth interviews (&gt; 40) with healthcare workers, caregivers, EPI focals and community leaders across 10 districts. Both will be combined for one overall comprehensive report on the barriers to MCV2 across the Oromia Region. Increasing the awareness on the demand for MCV2 is complete through radio messaging in the local language across the Region, and also ongoing demand generation activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">a) The quantitative analysis is underway, pending the final report. b) The report of results from the qualitative portion of the barriers analysis, led by researchers at Addis Ababa University, has been completed. This report provides information on approaches for increasing access to and uptake of MCV2 in Oromia Region.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">a) Start planning for barriers study, b, c, e) report status; draft materials developed for catch-up vaccination in line with MCV2 introduction; d) assessment of impact of current messaging</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The study completed the field work, and the analysis and write up is ongoing. Supportive supervision and enhanced strategies for catch-up of MCV2 is being provided across the Region. Additional MCV2 messaging has rolled out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity or Accessibility assessment performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="EPI performance review and/or MSD supported and  progress documented">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Immunization performance for the EFY 2013 was reviewed at MoH level with the presence of MoH, RHB and zonal level EPI officer, consultants, and other EPI partners. Besides, Amhara, Oromia, SNNP and Sidama regions also reviewed annual performance. Consultants deployed by UNICEF through contribution from GAVI TCA fund in 14 zones and three regional health bureaus supported the review process and documentation of progresses, challenges, and lesson. UNICEF with Government EPI officers and team leads from 14 zones and four targeted regions also reviewed the performance of routine immunization and lessons. UNICEF with WHO prepared routine immunization improvement plan which is endorsed by the MoH. In UNICEF supported zones, the administrative coverage for penta3 and MCV1 increased from 94% in 2018/19 to 100% in20/21 and MCV1 from 89% to 95% and MCV2 from 49% to 77% during similar period. Similarly, the dropout from penta1 to penta3 and penta1 to MCV1 dropped from 6% to % and 11% to 9% respectively. There is improvement in coverage and reduction of dropouts compared with average non-UNICEF targeted Zones.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In-depth assessement of data quality (DQR, DQA, audit) performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="EPI performance review and/or MSD supported and  progress documented">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The activity described here is not in line with the milestone. However, EPI performance review for EFY 2013 will be held by next quarter. UNICEF will provide technical and financial support. The detail progress will be reported in November 2021 when the activity is completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization service avilability monitored  biannually by type of HFs in 14 Zones  and at least one advocacy meeting conducted per zone for service expantion">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">As per the national health facility standard, all health facilities in Ethiopia are supposed to provide immunization services. However, as per the 2018 service availability and readiness assessment (SARA) only about 81 per cent of health facilities were providing immunization service. Nearly one out of five health facilities were not able to provide immunization service. It is important to monitor the proportion of health facilities providing immunization service and reasons for why some health facilities are not providing services in UNICEF supported zones. Through identifying the reasons context specific support provided to start offering immunization service. In 2021, in UNICEF supported 14 Zones 1024 (25.7%) health centers and 4967 (29%) health posts were identified from master health facility list and checked whether the health facilities reported immunization service at least for more than three months biannually. A total of 93 health facilities (12 in Sidama and 81 in SNNP) are supported to provide immunization service. The monitoring system is initiated by UNICEF deployed consultants embedded in zones/region health offices. The monitoring system is established with regular reporting system through DHIS2 which is simple to monitor health facility service provision status for their respective jurisdiction and can be done and sustained by government programme officers. However, in UNICEF supported two zones of Amhara and two zones of Oromia a total of 224 HCs and 915 health posts are affected by recent security escalation and interrupted services. UNICEF is supporting at regional states to prepare the catchup plans.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data improvement field activity implemented (review, validation, monitoring, harmonisation, mentorship, workshop, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification , mapping, and targeting through REC micro-plan preparation to reach  missed/underserved communities in six zones with high number of zero dose children">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">GAVI TCA fund through UNICEF has supported 153 woreda health offices and 570 health centers in Sidama, three zones in SNNP and four zones in Oromia region to identify, map, and target underserved villages and prepare micro-plans. A total of 1410 (871 in Oromia region and 539 SNNP) underserved villages were identified and mapped during the micro-planning. The identification and mapping of the underserved villages helped to reach zero dose and under vaccinated children. Immunization service provided in 8594 session (5190 in Oromia and 3378 in SNNP) of which 2799 fixed and 5795 outreaches. A total of 1849 children aged 12 to 23 months were checked for their vaccination status through rapid community survey. The result showed 88, 78 and 36 per cent coverage for penta3, MCV1 and MCV2 respectively. In general, there is considerable gap between administrative and community survey data where administrative data is higher often 100+ for the first dose of penta1 and penta3.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity or Accessibility assessment performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification , mapping, and targeting through REC micro-plan preparation to reach  missed/underserved communities in six zones with high number of zero dose children">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Identification of under served communities, mapping and targeting for immunization service is critical to ensure equitable access and use of services. Learning from previous UNICEF supported Zones, Oromia and Amhara regional health bureaus requested UNICEF to expand technical and financial support. However, as support is limited the RHBs opted to shift TAs to new zones where the capacity is relatively low. Accordingly, Oromia and Amhara regional health bureaus shifted UNICEF deployed TAs into four and two new zones respectively. 
In four Zones of Oromia region (67%) about 526 underserved/risk communities were identified under 301 PHCU catchments and 68 woredas. The identification and mapping were conducted by organizing 12 RED/REC workshops through engaging 518 woreda and health center managers and EPI focal persons for three days. The underserved community was identified based on geographic, topographic, other social characteristics, analyzing service provision modalities and settlements. Besides, immunization coverage pattern, defaulter rate, incidence of measles outbreak in health facility catchments were considered for identification of low performing health facilities and underserved communities. Then the health facilities were prioritized, and the underserved communities were mapped in each health facility catchment. Each health facility target and plan appropriate service delivery modality as per the local context. Accordingly, the number of service delivery points are expanded. In two zones of Amhara, REC micro planning is currently ongoing. Technical support will be provided to PHCUs and woreda to be able follow up and regularly monitor the access and use of services using a package of monitoring tools. Immunization service will be an indicator for community score card. Facility community linkage will be strengthened for sustaining services. The programme trigger additional health post construction will be initiated in isolated and remote villages</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Master facility list platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization service avilability monitored  biannually by type of HFs in 14 Zones  and at least one advocacy meeting conducted per zone for service expantion">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Immunization service availability from health facilities monitored in UNICEF supported 14 Zones. Health facilities not providing immunization services were reduced from 617 to 440 (29% reduction from March 2020 to March 2021) in 14 UNICEF supported Zones. In total immunization service expanded to 177 additional health facilities with one year. Reasons for not providing immunization service were multiple including, availability of health post and Health center in the same compound so that HC not provided immunization, non-functional refrigerator, shortage of trained human resource, conflict and negligence. Advocacy and performance review meetings have been conducted in seven zones of SNNP and Oromia (50% achievement). UNICEF consultants collected data on immunization service provision status and identified for barriers by woreda. Immunization service status and performance was presented and discussed in the review and advocacy meeting where zonal and woreda health managers are participated One of the key actions following the meeting was to expand immunization service in health facilities where there was no immunization service. UNICEF consultants with zonal and woreda EPI officers provided technical support and monitor service commencement and/or resumption immunization service. The advocacy and performance review meeting has contributed to start immunization service in health facilities that were not providing before. While Zonal advocacy and review meeting will be held in Amhara and Sidama integrating with other COVID-19 vaccine rollout.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coverage survey conducted  in at least 70 villages far from health facilities and risk communities in 14 zones to generate evidence on zero dose and under vaccination">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">In UNICEF supported zones there are 1024 Health centers and 4967 health posts. During the reporting period, UNICEF deployed consultants supervised 345 (33.7%) health centers and 345 (7%) Health posts in the target zones. The consultants also conducted data quality verification in 266 health posts and monitored 117 immunization sessions at static and outreach sites. 
 Rapid community survey was conducted in 311 villages to check vaccination status among 3420 children aged 12 to 23 months. The data verification findings showed that only 67% reported within acceptable range, while 21% over reported and 12% were under reporting. The overreporting increase for the later doses for penta3, MCV1 and MCV2. The session monitoring results indicated that among the 35 outreach sessions only 30% were supported by community members (HAD) which indicated fatigue of the community platform. Home based registration cards were provided in 77% visited sessions. Regarding key messages, about 82%, 64%, 55% and 54% communicated about when to return or appointment date, possible side effects, keeping the vaccination card and about the vaccine type. 
The rapid community survey results showed that 95.6%, 89.8%, 80.4% coverage for penta1, penta3 and MCV1 respectively. The dropout rate from penta1 to penta3 and penta1 to MCV1 was 7 and 16.8% respectively.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine immunisation coverage survey (national /targeted - various methods) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coverage survey conducted  in at least 70 villages far from health facilities and risk communities in 14 zones to generate evidence on zero dose and under vaccination">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF supported 14 Zones with high number of unvaccinated children benefiting 30.4 million (27.8%) of the total population. During the first half of the year 2021 local rapid community surveys were conducted in 75 villages of (107%) achievement. A total of 932 children aged 0 to 23 were surveyed. Home based registration card (HBR) was found only for 63% and 58% of 0 to 11 and 12 to 23 months aged children respectively. Community surveys revealed shortage and unavailability of HBR card in many health facilities particularly in health posts. The rapid community survey coverage among surveyed children for tracer antigens were 96%, 87% and 77% for Penta 1, Penta 3 and MCV1 respectively. Out of 615 children aged 12 to 23 months, about 77% were fully vaccinated, 20% were defaulters and 3% were never vaccinated. Penta1 coverage is high in line with administrative coverage whereas the latter doses were low which indicated considerable proportion of under immunized children. Caregivers were asked why the dropped from vaccination and main responses were lack of information on the date of vaccination, vaccinator absent, computing priorities and fear of multiple injection and adverse events following immunization. Thus, concerted effort is required to address the defaulters.
There are villages with and without mobile network coverage. Availability of mobile phone in the household was not assessed. This is important parameter and will include in the immunization status assessment tool. Community health workers are there but only 29% of outreach sessions were supported by volunteer community health workers. There was HBR shortage at national level. The MoH is printing HBR and soon it will be available in health facilities. Local radio is available in many places and contributing for disseminating messages.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs have a list of woredas with planned review meetings (incl PIRI/MCV2). Technical assistance provided to priority woredas for the preparation of PIRI/MCV2 related review meetings, including coaching/on-job support and guidance documents or templates as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist Afar and Somali RHBs in coordination and support regarding prep and follow-up of review meetings and provide technical assistance to select woredas conducting immunization (including PIRI/MCV2) review meetings.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Both regions identified woredas that needed follow up and support for improving uptake of MCV2 and support for PIRI. A total of 43 woredas in the two regions (29 in Somali and 14 in Afar) were prioritized by RHB for technical assistance for review meetings.
 
In Somali region, a regional level review meeting was organized by RHB in July 2021 where most of the PIRI/MCV2 poor-performing woredas attended. JSI provided technical assistance to the RHB and woredas to ensure gaps were understood and clear action points were set. Clear guidance for provision of MCV2 as part of other routine immunization was given to all woredas by RHB. The project also provided technical assistance to zonal level review meetings organized in two zones: Fafan zone (where 14 woredas attended) and Jarar zone (where 8 prioritized woredas attended). For other zones in the region, the project supported zonal level review meetings virtually through advising via phone and discussion with RHBs. For all zones, the analysis on MCV2 uptake and facilities not providing MCV2 was shared for use during their zonal and woreda level review meetings. 
In Afar region, the support for review meeting was done at woreda level. Technical assistance was provided in person at three woreda-level review meetings, where action points were developed to improve PIRI/MCV2. The RHB also attended the review meetings. For other 11 prioritized woredas, the project provided technical assistance on organizing review meeting remotely. The main issues and agenda discussed during the review meetings included: RI performance status, gaps and challenges of 2021, MCV1 and MCV2 specific performance status of 2020 and 2021 and gaps, and other RMNCH performance status of 2021. During the review meetings, JSI provided technical assistance on identification of data from DHIS2, development of agenda and PPT presentation, as well as follow-on on-job support and coaching based on the gaps identified during the review meeting.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist Afar and Somali RHBs in coordination and support regarding prep and follow-up of review meetings and provide technical assistance to select woredas conducting immunization (including PIRI/MCV2) review meetings.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Both regions identified woredas that needed follow up and support for improving uptake of MCV2 and support for PIRI. A total of 43 woredas in the two regions (29 in Somali and 14 in Afar) were prioritized by RHB for technical assistance for review meetings.
 
In Somali region, a regional level review meeting was organized by RHB in July 2021 where most of the PIRI/MCV2 poor-performing woredas attended. JSI provided technical assistance to the RHB and woredas to ensure gaps were understood and clear action points were set. Clear guidance for provision of MCV2 as part of other routine immunization was given to all woredas by RHB. The project also provided technical assistance to zonal level review meetings organized in two zones: Fafan zone (where 14 woredas attended) and Jarar zone (where 8 prioritized woredas attended). For other zones in the region, the project supported zonal level review meetings virtually through advising via phone and discussion with RHBs. For all zones, the analysis on MCV2 uptake and facilities not providing MCV2 was shared for use during their zonal and woreda level review meetings. 
In Afar region, the support for review meeting was done at woreda level. Technical assistance was provided in person at three woreda-level review meetings, where action points were developed to improve PIRI/MCV2. The RHB also attended the review meetings. For other 11 prioritized woredas, the project provided technical assistance on organizing review meeting remotely. The main issues and agenda discussed during the review meetings included: RI performance status, gaps and challenges of 2021, MCV1 and MCV2 specific performance status of 2020 and 2021 and gaps, and other RMNCH performance status of 2021. During the review meetings, JSI provided technical assistance on identification of data from DHIS2, development of agenda and PPT presentation, as well as follow-on on-job support and coaching based on the gaps identified during the review meeting.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs monitor capacity building plans and assess status using existing coordination and discussion mechanisms (e.g., technical working group meetings)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">During the reporting period, JSI supported Afar and Somali RHBs to implement and monitor the capacity building plans they?d developed. The capacity building plan included actions and activities to be carried out in each region to ensure successful rollout of PIRI and scale up of MCV2 within the health system. Based on the plan, technical assistance was provided to the RHBs and the progress of the plan was monitored regularly with the RHB and TWGs. 
JSI provided technical assistance and on-job training to RHB team on extracting data from DHIS2 and analysis of the performance of each woreda using RED categorization tool, follow up action points, and communication with woredas. Based on data analysis, both regions developed a list of priority woredas for targeted assistance (29 woredas in Somali and 18 woredas in Afar were prioritized due to poor MCV2 performance). In Afar, all hard-to-reach kebeles within the region were identified; this information was used to update the specific areas to be targeted using PIRI resources.
For woredas with consistent poor performance on PIRI/MCV2, JSI provided supportive supervision to the woredas (three rounds per region) to identify challenges and provide clear action points to improve the status of the woredas and health facilities. In Somali, SS was provided to 10 WoHO, 18 HC and 30 HPs; in Afar, SS was provided to 10 WoHO, 14 HC, and 10HP. All SS visits were conducted together with RHB staff, as an additional opportunity to build capacity of RHB staff to problem solve and monitor progress of the program.
Additionally, JSI provided technical assistance to the RHBs during the rollout of immunization related trainings (IIP, IRT and MLM) using MoH resource from PIRI. MCV2 was included in all PIRI-funded trainings provided in both regions.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">During the reporting period, JSI supported Afar and Somali RHBs to implement and monitor the capacity building plans they?d developed. The capacity building plan included actions and activities to be carried out in each region to ensure successful rollout of PIRI and scale up of MCV2 within the health system. Based on the plan, technical assistance was provided to the RHBs and the progress of the plan was monitored regularly with the RHB and TWGs. 
JSI provided technical assistance and on-job training to RHB team on extracting data from DHIS2 and analysis of the performance of each woreda using RED categorization tool, follow up action points, and communication with woredas. Based on data analysis, both regions developed a list of priority woredas for targeted assistance (29 woredas in Somali and 18 woredas in Afar were prioritized due to poor MCV2 performance). In Afar, all hard-to-reach kebeles within the region were identified; this information was used to update the specific areas to be targeted using PIRI resources.
For woredas with consistent poor performance on PIRI/MCV2, JSI provided supportive supervision to the woredas (three rounds per region) to identify challenges and provide clear action points to improve the status of the woredas and health facilities. In Somali, SS was provided to 10 WoHO, 18 HC and 30 HPs; in Afar, SS was provided to 10 WoHO, 14 HC, and 10HP. All SS visits were conducted together with RHB staff, as an additional opportunity to build capacity of RHB staff to problem solve and monitor progress of the program.
Additionally, JSI provided technical assistance to the RHBs during the rollout of immunization related trainings (IIP, IRT and MLM) using MoH resource from PIRI. MCV2 was included in all PIRI-funded trainings provided in both regions.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs develop a capacity building plan utilizing findings of status review in coordination with partners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">In coordination with RHB and partners, both Afar and Somali RHBs have developed action and capacity building plans for the region to improve PIRI and MCV2 based on the areas of most need. Going forward, embedded regional staff will support the RHB in the implementation and monitoring of the plan.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">In coordination with RHB and partners, both Afar and Somali RHBs have developed action and capacity building plans for the region to improve PIRI and MCV2 based on the areas of most need. Going forward, embedded regional staff will support the RHB in the implementation and monitoring of the plan.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs have PIRI and MCV2 status reviewed and situation analysed and summarized into one report per region.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review of PIRI and MCV2 performance status and situation analysis in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">JSI conducted a rapid situational analysis (SA) on the implementation of PIRI and MCV2 in Afar and Somali regions. The objective of the Rapid SA was to examine the current implementation status of PIRI and MCV2 in Somali and Afar regions to improve understanding of program success, gap or challenge areas, and priority actions needed. The findings provided information to each RHB and the MOH for better planning, implementation, and monitoring of these activities as well as further refining the planned regional level technical assistance from JSI. Findings were presented at national level through a briefing to the EPI team at MOH, as well as during a national level TCA coordination meeting for expanded partners conducted at Adama. At regional level, findings were presented at the regional TWG in each region. The Rapid SA methodology, findings, and recommendations are summarized in the attached report.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review of PIRI and MCV2 performance status and situation analysis in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">JSI conducted a rapid situational analysis (SA) on the implementation of PIRI and MCV2 in Afar and Somali regions. The objective of the Rapid SA was to examine the current implementation status of PIRI and MCV2 in Somali and Afar regions to improve understanding of program success, gap or challenge areas, and priority actions needed. The findings provided information to each RHB and the MOH for better planning, implementation, and monitoring of these activities as well as further refining the planned regional level technical assistance from JSI. Findings were presented at national level through a briefing to the EPI team at MOH, as well as during a national level TCA coordination meeting for expanded partners conducted at Adama. At regional level, findings were presented at the regional TWG in each region. The Rapid SA methodology, findings, and recommendations are summarized in the attached report.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs have mapped partners working on MCV2 and PIRI, and list partners by area of support and geography. Afar and Somali RHBs will organize a partners meeting and/or use existing coordination platforms to share situational analysis findings and develop a coordinated regional plan of action.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mapping of partners and harmonization of implementation plans for PIRI/MCV2 in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Partner mapping was completed as part of each region?s Rapid Situational Analysis (SA). Overall, there is varied support related to immunization being provided in both regions, but often concentrated in select woredas. At the regional level, coordination for immunization activities is done mainly through technical working group meetings with RHB and active partners. Additional results are included in the Rapid SA Report. 
After conducting partner mapping, both regions organized a meeting with their respective RHBs and immunization partners to present the Rapid SA findings and to develop an action plan based on the report recommendations. Both Afar and Somali held their meetings as part of the regional TWG in March 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mapping of partners and harmonization of implementation plans for PIRI/MCV2 in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Partner mapping was completed as part of each region?s Rapid Situational Analysis (SA). Overall, there is varied support related to immunization being provided in both regions, but often concentrated in select woredas. At the regional level, coordination for immunization activities is done mainly through technical working group meetings with RHB and active partners. Additional results are included in the Rapid SA Report. 
After conducting partner mapping, both regions organized a meeting with their respective RHBs and immunization partners to present the Rapid SA findings and to develop an action plan based on the report recommendations. Both Afar and Somali held their meetings as part of the regional TWG in March 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Document on partners mapping by geography and specific areas of support. MOH develops or adapts a simplified tool/checklist used to monitor and follow up implementation as per PIRI protocol and MCV2 rollout.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Regions submitted quarterly PIRI performance reports to national level for monitoring. Through its embedded national level advisor, JSI facilitated regular data analysis and monitoring on the progress of PIRI rollout and MCV2 coverage during the implementation period. Data from July 2020-February 2021 showed MCV2 72% and MCV1 87% at national level; 53% MCV2 coverage for Somali; 51% of MCV2 for Afar region. MCV2 data analysis conducted by JSI for FMOH and regions is attached. JSI also provided support to various MOH priority activities in its workplan related to improving MCV2 uptake, PIRI, and routine immunization overall. For example, an MCV2 job aid was developed in English and shared in late 2020, with printing/distribution to select areas provided by USAID Transform HDR Project. Currently, the job aid is being translated to Amharic and Somali languages, pretested for clarity, functionality, and quality, and will be further printed and disseminated to woredas where MCV2 is lagging. The pretesting plan for Amharic/Somali versions is attached. In addition, JSI participated in the integrated supportive supervision (ISS) during the reporting period. The TA visited Somali region?s Harshin and Awbera woredas, using a standard checklist revised to include MCV2 and PIRI related indicators. ISS feedback was provided on-site to health workers at health facility, woreda, and RHB levels; a national level debriefing was conducted for the MOH management team. Lastly, JSI participated in an MCV2 advocacy meeting in Gambella region, integrated with COVID-19 activities. Representatives from RHB MCH department, woreda health offices, religious leaders, other sectors (e.g. education), and partners were present. During the meeting, JSI delivered a presentation on the current status of MCV2 and implementation challenges. IEC materials were shared to participants and action points were developed to conduct catch-up and various social mobilization activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Regions submitted quarterly PIRI performance reports to national level for monitoring. Through its embedded national level advisor, JSI facilitated regular data analysis and monitoring on the progress of PIRI rollout and MCV2 coverage during the implementation period. Data from July 2020-February 2021 showed MCV2 72% and MCV1 87% at national level; 53% MCV2 coverage for Somali; 51% of MCV2 for Afar region. MCV2 data analysis conducted by JSI for FMOH and regions is attached. JSI also provided support to various MOH priority activities in its workplan related to improving MCV2 uptake, PIRI, and routine immunization overall. For example, an MCV2 job aid was developed in English and shared in late 2020, with printing/distribution to select areas provided by USAID Transform HDR Project. Currently, the job aid is being translated to Amharic and Somali languages, pretested for clarity, functionality, and quality, and will be further printed and disseminated to woredas where MCV2 is lagging. The pretesting plan for Amharic/Somali versions is attached. In addition, JSI participated in the integrated supportive supervision (ISS) during the reporting period. The TA visited Somali region?s Harshin and Awbera woredas, using a standard checklist revised to include MCV2 and PIRI related indicators. ISS feedback was provided on-site to health workers at health facility, woreda, and RHB levels; a national level debriefing was conducted for the MOH management team. Lastly, JSI participated in an MCV2 advocacy meeting in Gambella region, integrated with COVID-19 activities. Representatives from RHB MCH department, woreda health offices, religious leaders, other sectors (e.g. education), and partners were present. During the meeting, JSI delivered a presentation on the current status of MCV2 and implementation challenges. IEC materials were shared to participants and action points were developed to conduct catch-up and various social mobilization activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MOH convenes partners to review progress to date on PIRI implementation, completion/timeliness of reporting, and other implementation issues.  Coordination/support visits conducted to priority RHBs.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Through an embedded national advisor, JSI provided full-time support to the EPI with a focus on improving PIRI implementation and strengthening MCV2 uptake. JSI supported the analysis of administrative data (DHIS2) for MCV1/MCV2 and provided feedback to lower levels on key findings. JSI also prepared national EPI program and RMNCH directorate programs review meeting presentations, highlighting key data and issues related to PIRI activities and MCV2 delivery. To address the effects of acute security situations, JSI compiled a list of about 270 conflict and IDP affected woredas and prepared a costed proposal to support vaccination response activities integrated with PIRI. 
To improve knowledge gaps at health facility level, JSI had prepared an MCV2 job aid. During this reporting period, the job aid was pre-tested and translated to Amharic and Somali languages, and 2000 copies were printed and distributed (600 to Somali region, and 1400 Amharic copies to Afar, Benishangul Gumuz, Amhara, and SNNPR regions). JSI briefed regional EPI focals and immunization partners over Zoom on how to introduce and use the job aid. 
JSI also began preparatory activities for the development of a national catch up vaccination guide, which is planned to be completed in the subsequent TCA contract. JSI briefed EPI and ensured its inclusion in the MOH?s overall workplan, briefed the national technical working group on rationale and overall activity, established a sub working group, developed an outline, and began discussions on key technical decisions in the guide (e.g. establishing a catch up schedule with upper age limits). JSI also supported partner coordination by participating in the Oct 2021 Gavi TCA coordination meeting.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Through an embedded national advisor, JSI provided full-time support to the EPI with a focus on improving PIRI implementation and strengthening MCV2 uptake. JSI supported the analysis of administrative data (DHIS2) for MCV1/MCV2 and provided feedback to lower levels on key findings. JSI also prepared national EPI program and RMNCH directorate programs review meeting presentations, highlighting key data and issues related to PIRI activities and MCV2 delivery. To address the effects of acute security situations, JSI compiled a list of about 270 conflict and IDP affected woredas and prepared a costed proposal to support vaccination response activities integrated with PIRI. 
To improve knowledge gaps at health facility level, JSI had prepared an MCV2 job aid. During this reporting period, the job aid was pre-tested and translated to Amharic and Somali languages, and 2000 copies were printed and distributed (600 to Somali region, and 1400 Amharic copies to Afar, Benishangul Gumuz, Amhara, and SNNPR regions). JSI briefed regional EPI focals and immunization partners over Zoom on how to introduce and use the job aid. 
JSI also began preparatory activities for the development of a national catch up vaccination guide, which is planned to be completed in the subsequent TCA contract. JSI briefed EPI and ensured its inclusion in the MOH?s overall workplan, briefed the national technical working group on rationale and overall activity, established a sub working group, developed an outline, and began discussions on key technical decisions in the guide (e.g. establishing a catch up schedule with upper age limits). JSI also supported partner coordination by participating in the Oct 2021 Gavi TCA coordination meeting.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assist regions to send HPV performance report through DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist routinizing HPV report through DHIS 2 by reporting in to routine HIS">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Both HPV dose 1 and dose 2 are continued to be reported via the DHIS2 system to the national level monthly including zero reporting. HPV vaccine uptake and coverage data were analyzed, presented, and discussed during the Reproductive, maternal neonatal, and child health; Adolescent and Youth and Nutrition (RMNCHAY-N) annual review meeting.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participate on national and regional WGs and assist planning and implementation of SBCC work</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participation in advocacy and coordination between national &amp; regional levels in Afar and Somali">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Coordinated and facilitated National advocacy and consultative workshop among RHBs and regional Teachers&apos; Association representatives</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participate on national and regional TWGs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participation in national TWG, M&amp;E task force and Training task force for 4th year HPV planning and preparation">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Engagement continuing in the National TWG (ME and social mobilization sub-working group).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Improved HPV coverage</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to implemention recommendations from HPV PIE">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Key HPV recommendations were developed and shared with RHBs for implementation. RHBs started implementing the recommendations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One woreda selected per region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity buidling training for HCWs in creation of model woreda on service provision &amp; data quality">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Model Woreda has not yet been selected. A Woreda will be selected in consultation with Afar and Somali RHBs in December when both regional HPV coordinators are on board.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MSD/JA report and One TA Plan finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist successful Gavi joint appraisal/MSD meetings by organizing One TA/MSD report finalization workshop">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Not yet conducted. It is under discussion with MOH/EPI.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Virtual orientation provided</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct on site support during HPV campaign and assist virtual orientation. Technical Assistance and Vehicle support for a HPV campaign by maintaining infection prevention and control principles.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The campaign has been re-scheduled for the 1st week of December due to COVID-19 vaccination rollout in a campaign mode nationally to avert the transmission. virtual orientation will be conducted 4th week of November.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementations of policy/cMYP</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy,  implementation guide and cMYP development and write up meetings to revise/update the national IIP training modules">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy, implementation guide and cMYP 
?	The consultative workshop was conducted in June 2021 and the cMYP planning document production finalized; 2021-2025 c MYP finalization workshop supported which enables the country to produce the five years immunization plan</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy,  implementation guide and cMYP development and write up meetings to revise/update the national IIP training modules">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy, implementation guide and cMYP 
?	The consultative workshop was conducted in June 2021 and the cMYP planning document production finalized; 2021-2025 c MYP finalization workshop supported which enables the country to produce the five years immunization plan</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All live sites have system with new features</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Add new features to mBrana to comply with TSS">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Please see progress report attached.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Add new features to mBrana to comply with TSS">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Please see progress report attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">75 new sites with live data visibility, and ordering electronically</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Deploy new system to 75 new sites.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Please see progress report attached.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Deploy new system to 75 new sites.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Please see progress report attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One person from EPI case team trained in advanced vaccinology training abroad</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support one person from the MoH/EPI for vaccinology course abroad">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Because of the budget shortage the vaccinology course was not supported in this reporting period</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support one person from the MoH/EPI for vaccinology course abroad">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Due to budget shortage the activity not conducted in the reporting period</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identification of the institute and ensure admission for the course</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support one person from the MoH/EPI for vaccinology course abroad">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Post ponded due to COVID pandemic and budget shortage</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40-60% of trained health workers will develop operational micro planning including session planning to reach more &apos;0&apos; dose children in the selected zones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support training of health care workers in 12 priority zones in three big regions (Tigray, Amhara, Oromia) and one Benishangul Gumz region and , Addis Ababa and Dire Dawa City Administrations. (1) Train 100-120 Regions and EPI focals and experts on MLM (online and virtual and in persons) (2) Train 380-400 EPI experts working in health care facilities in Combined RED/IIP training and other Immunization in Actions interactive training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO facilitated and coordinated RED/IIP training in there GAVI priority regions. A total of 457 EPI experts Oromia (193) Amhara (80) and SNNPR (184) trained for 5 days with the aim to improve the knowledge and skill of health workers to provide quality immunization services</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Post training supportive supervision and review meeting in 40-60% of health facilities in the selected zones will be conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two rounds of annual post training supportive supervision and review meetings in the priority zones">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO facilitated and coordinated joint supportive supervision to identified challenges hampering routine immunization implementation and COVID vaccine uptake, teeth out best practices and lesson learned to be reported in the RMNCH conducted at national level</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">System for regular monitoring and supervision of vaccinators / FHWs in priority areas is in place, allowing for assessing trend in performance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two rounds of annual post training supportive supervision and review meetings in the priority zones">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has prepared a protocol and supervisory check list for the joint Supportive supervision. The joint assessment visit which WHO is part of the assessment group deployed more than 10 staffs and conducted for 15 days in all regions, including in 8 GAVI priority zones helped to evaluate data validation and data triangulation system.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two rounds of annual post training supportive supervision and review meetings in the priority zones">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">West Showa and ARSI zones of Oromia and South Gonder and AWI zones of Amhara region completed their preparation to conduct review meetings to see the progress made in the immunization program implementation and to document best practices.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Trained health workers will developing operational MP and session planning to improve service delivery in their catchment areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support training of health care workers in 12 priority zones in three big regions (Tigray, Amhara, Oromia) and one Benishangul Gumz region and , Addis Ababa and Dire Dawa City Administrations. (1) Train 100-120 Regions and EPI focals and experts on MLM (online and virtual and in persons) (2) Train 380-400 EPI experts working in health care facilities in Combined RED/IIP training and other Immunization in Actions interactive training">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">West Showa and ARSI zones of Oromia conducted IIP training for 207 health workers with the aim to improve the skill and knowledge of immunization officers, to build their capacity and enable them to provide quality immunization services. South Gondar and AWI zones of Amhara region have completed their preparation to conduct RED and IIP training for health. The remaining two zones of SNNPR and one zone of Tigray regions developed plan and submitted to WHO but because of the delay in the releasing of 2021 GAVI TCA funds implementation IIP training in these 3 zones will not be conducted in the reporting period</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of severe AEFI cases classified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.Support biannual &#xA0;meeting of national AEFI committees &#xA0;and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">?	Two TAs recruited to provide technical support for EFDA and EPHI, contributed for successful coordination of these two institutions. Technical Support provided to coordinate national AEFI committees and stakeholders meeting to investigate 9 serious AEFI after COVID vaccination. Regular AEFI committee zoom meeting undergoing to see the progress made</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.Support biannual &#xA0;meeting of national AEFI committees &#xA0;and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">?	Two TAs recruited to provide technical support for EFDA and EPHI, contributed for successful coordination of these two institutions. Technical Support provided to coordinate national AEFI committees and stakeholders meeting to investigate 9 serious AEFI after COVID vaccination. Regular AEFI committee zoom meeting undergoing to see the progress made</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Reach &gt;95% of targeted children</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.    Provide technical support to implement:                                                                                                                                                        ?   PIRI in the targeted zones                                                                                                                                                                              ?    AVW in the targeted zones                                                                                                                                     ?   roll out of MCV2 to all health facilities and implementation of HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Provide technical support to implement: ? 
?	PIRI in the targeted zones: Planned PIRI could not be conducted in 2020 due to COVID-19 Pandemic ? 
?	AVW: The 2021 AVW is panned to be conducted in the coming two weeks. WHO is supporting the communication and avocacy materialsproductin and spo Radio/TV messages in which it is nearly completed. 
?	Roll out of MCV2 to all health facilities: MCV2 is rolled out in more than 90% of the health facilities in the country. Enables the country to increase population immunity and reduce Measles outbreaks 
?	HPV vaccinations: Ethiopia has conducted an integrated HPV vaccination for 2019 and 2020 cohort, in and out of school-girls of age 14 years. The 2019 cohort, second round HPV vaccination could not be conducted due to COVID pandemic. The second dose HPV vaccination of 2019 cohort and first round HPV vaccination of 2020 cohort conducted in January 2021 . WHO recruited Nine technical assistance with their rented vehicles and posted them in the nine zones of four GAVI priority regions and two city administrations. the deployment of the consultants contributed for success full HPV vaccination. As a result, 81.5% of girls age 14 years of 2019 cohort vaccinated for second dose. and 91.5% of girls age 14 years of 2020 cohort vaccinated for first dose.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.    Provide technical support to implement:                                                                                                                                                        ?   PIRI in the targeted zones                                                                                                                                                                              ?    AVW in the targeted zones                                                                                                                                     ?   roll out of MCV2 to all health facilities and implementation of HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Provide technical support to implement: ? 
?	PIRI in the targeted zones: Planned PIRI could not be conducted in 2020 due to COVID-19 Pandemic ? 
?	AVW: The 2021 AVW is panned to be conducted in the coming two weeks. WHO is supporting the communication and avocacy materialsproductin and spo Radio/TV messages in which it is nearly completed. 
?	Roll out of MCV2 to all health facilities: MCV2 is rolled out in more than 90% of the health facilities in the country. Enables the country to increase population immunity and reduce Measles outbreaks 
?	HPV vaccinations: Ethiopia has conducted an integrated HPV vaccination for 2019 and 2020 cohort, in and out of school-girls of age 14 years. The 2019 cohort, second round HPV vaccination could not be conducted due to COVID pandemic. The second dose HPV vaccination of 2019 cohort and first round HPV vaccination of 2020 cohort conducted in January 2021 . WHO recruited Nine technical assistance with their rented vehicles and posted them in the nine zones of four GAVI priority regions and two city administrations. the deployment of the consultants contributed for success full HPV vaccination. As a result, 81.5% of girls age 14 years of 2019 cohort vaccinated for second dose. and 91.5% of girls age 14 years of 2020 cohort vaccinated for first dose.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Dissemination workshop</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.Conduct Dropouts/MOV assessment in selected zones to determine the magnitude and reasons ofDropouts/ MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-programmed</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.Conduct Dropouts/MOV assessment in selected zones to determine the magnitude and reasons ofDropouts/ MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">This activity was re-programmed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of NITAG meetings held and 100% of NITAG recommendations implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Support NITAG/ICCC and EPI coordination mechanisms (TWGs) by meetings by preparing agendas, documents and prepare presentations and record recommendation: Support the training and field visits whenever possible">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Regular and ad-hoc e NITAG meetings facilitated. WHO involved in preparation of agendas , back ground documents presentation and minutes</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Support NITAG/ICCC and EPI coordination mechanisms (TWGs) by meetings by preparing agendas, documents and prepare presentations and record recommendation: Support the training and field visits whenever possible">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">planned NITAG meetings conducted advice from NITAG well taken and ICC meeting recommendations on COVID vaccine introduction implemented. Technical support provided to coordinate regular meeting of different TWGs. Prepared zoom meetings, design agendas and prepared presentation on the new vaccines updates and monitored progress of new vaccine introduction including COVID vaccination</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Organize a consultative workshop to finalize the EPI policy, cMYP documents</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy, implementation guide and cMYP development and write up meetings">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The consultative workshop was conducted in June 2021 and the cMYP planning document production finalized; 2021-2025 c MYP finalization workshop supported which enables the country to produce the five years immunization plan</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI policy and cMYP completed and endorsed by NITAG and ICC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy, implementation guide and cMYP development and write up meetings">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">two days consultative workshop organized to finalize c MYP document which is letter endorsed by FMOH and ICC</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Risk communication plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EPI on development of crisis/risk communication plan of action on routine immunization and new vaccine introduction such as nOPV2 (Comment: I thought this was planned by Covax/Gavi TCA so what makes it different | Reply: This will be for routine immunizatio nand nOPV2.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Crisis communication plan on nOPV2 was developed and endorsed before the introduction of the vaccine introduction. Workshop on finetuning of National Guideline for Vaccine Safety, Risk and Crisis Communication was conducted in October 2021. Now it is in the process of revising by using inputs from the workshop.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">three Community engagement strategy for high risk communties is implemented in 14 zones in Amhara,SNNPR and oromia</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake Key activities 1 Develop and implement tailored behavior and social changes strategy for remote rural, urban scattered communities , conflict affected and communities with low socio-economic status and implementation in 14 zones in Amhara Oromia and SNNPR 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC 3. Strengthen SBCC coordination at regional level and in 14 UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 4. Support MCV2 , Measles SIA and NVI roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">During the reporting period, UNICEF ECO has been able to apply Human Centered Design thinking approach (HCD) for the development of tailored demand interventions in Oromia and SNNP regions. A national C4D consultant for tailored demand generation strategies is recruited on 20th Feb 2021 until 19 November 2021. The consultant has been trained and mentored on application Human Centered Design thinking approach with technical support of The Nucleus, an agency contracted by EASRO/HQ. By the reporting period, rapid inquiries have been conducted with participation of Regional Health Bureau, health workers, caregivers and community members. Under TCA 2021, it is already planned to proceed with ideation, prototyping, implementation, scale up and monitoring and evaluation for urban-poor communities in Oromia and rural-poor communities in SNNP which have the high number of zero-dosed and under-immunized children.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to overcome vaccine demand-related barriers in high risk communities developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building of EPI/health promotion officers from prioritized zones of Amhara, Oromia and SNNP on Human Centered Design Thinking approach for contextualized immunization demand generation">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">?Introduction to Human Centered Designed thinking approach; Creating demand for health and immunization services? which is one and half hour virtual session was conducted on 5th April 2021. About (50) participants who are representatives from Ministry of Health, Communication and Community Engagement Technical Working Group members, and EPI/C4D focal from regional offices were participated in this session. It was facilitated by The Nucleus, contracted by UNICEF EASRO/HQ. Following the orientation session, Master Classes on HCD which is a 3-day (3 hours per day) TOT training was conducted on 6-8 April 2021. About (30) participants from the regional offices and country office attended the training including interactive exercises. Training at the regional level is in the planning process.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prototyping of demand generation intervention by using human centered design thinking approach in peri-urban communities of Oromia which has highest number of zero-dosed children">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Before the HCD TOT training, rapid inquiry by utilizing HCD approach was conducted with participation on the Oromia Regional Health Bureau, woreda-level health workers, caregivers and community leaders. Key barriers to routine immunization services has been identified. In the second half of 2021, it is planned to conduct ideation session and prototyping of prioritized intervention which is tailored for the peri-urban communities in Oromia region.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building of EPI/health promotion officers from prioritized zones of Amhara, Oromia and SNNP on Human Centered Design Thinking approach for contextualized immunization demand generation">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">National-level TOT training and orientation session on application of HCD has been conducted in April 2021 with participation of national and sub-national level EPI/C4D focal. About 46 participants participated in the orientation session and about 33 participants from the Ministry of Health, Regional Health Bureau, and partners participated in the 3-day training. Participants are from different regions across the country. Partner agency, Emory University, also participated in the training for application of MCH service demand in Beninshangul-Gumuz and Afar regions as well. Training package on application of HCD for immunization demand has been developed for subnational EPI officers/health promotion officers. There is an ongoing discussion with RHB/FO on the training dates which are tentatively planned in Dec 2021 and Jan 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementation of C4I activities at the community level in the prioritized zones are monitored.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitoring on the implementation of community engagement activities in prioritized zones of Amhara, SNNP and Oromia especially on the participation of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Starting from early March 2021, 2 C4D Officers-UNV in Amhara Region, 2 in SNNP/Sidama regions and 2 in Oromia Region have been appointed and supporting on the monitoring of community engagement activities in an integrated manner. During September-November 2021, C4D-UNV conducted at least two field visits per region for integrated supportive supervision to the health centers and communities in Oromia, SNNP/Sidama and Amhara regions. In Amhara, a rapid assessment was conducted and it was higlighted SBC interventions on immunization and outbreak response such as measles need to be strenthen particularly among the IDP communities. UNICEF is currently supporting EPI team of MOH on development of simplified monitoring templated with standardized key indicators which will also be part of the national demand promotion on routine immunization plan of action.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MCV2, measles, SIA and NVI communication tools available at the regional level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake

Key activities
1 Develop and implement tailored behavior and social changes strategy for  remote rural, urban  scattered communities , conflict affected and communities with low socio-economic status and   implementation in 14 zones  in Amhara   Oromia and SNNPR  

 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC

3. Strengthen SBCC coordination at regional level  and  in 14   UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 

4. Support  MCV2 , Measles SIA and NVI   roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The development and implementation of tailored interventions in communities with high number of zero-dosed and under-immunized children are in process with application of Human Centered Design thinking approach. Monitoring activities are also ongoing with regional level presence of C4D UNV. With integration with COVID-19 RCCE and revitalization TWG, regional level coordination are revitalized as well. There is ongoing SBCC-related technical support on proposal development of Measles Campaign in 2022 and introduction of nOPV2 nation-wide synchronized campaign. Social and Behaviour Change Communication Strategy, Crisis Communication Plan and Advocacy Plan on nOPV2 introduction have been developed, endorsed by the MOH and verified for the upcoming synchronized nOPV2 vaccination campaign while communication materials are still in developing process.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake

Key activities
1 Develop and implement tailored behavior and social changes strategy for  remote rural, urban  scattered communities , conflict affected and communities with low socio-economic status and   implementation in 14 zones  in Amhara   Oromia and SNNPR  

 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC

3. Strengthen SBCC coordination at regional level  and  in 14   UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 

4. Support  MCV2 , Measles SIA and NVI   roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The development and implementation of tailored interventions in communities with high number of zero-dosed and under-immunized children are in process with application of Human Centered Design thinking approach. Monitoring activities are also ongoing with regional level presence of C4D UNV. With integration with COVID-19 RCCE and revitalization TWG, regional level coordination are revitalized as well. There is ongoing SBCC-related technical support on proposal development of Measles Campaign in 2022 and introduction of nOPV2 nation-wide synchronized campaign. Social and Behaviour Change Communication Strategy, Crisis Communication Plan and Advocacy Plan on nOPV2 introduction have been developed, endorsed by the MOH and verified for the upcoming synchronized nOPV2 vaccination campaign while communication materials are still in developing process.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in national 2nd Year implementation progress meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to FMOH to monitor 2nd Year HPV dose 2 implemention progress, identify challenges, propose solutions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">TA in HPV dose 2, postponed from previous cohort was completed. The national HPV 2 coverage is reported by FMOH as 82 %.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVMA performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted EVMA self-assessment in 85% of EPSA centre and hubs and 80% of districts at the 14 UNICEF supported zones, EVM Improvement plan developed; and attain EVM indicator for temperature (E2) at least 80% in 85% of the targets once in a year.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">As part of local capacity improvement on effective cold chain and vaccine management, woreda and health center conducted effective vaccine management self-assessment. Bases on self-assessment findings woreda and health facility vaccine and cold chain focal points are encouraged to prepare improvement plans and monitor progress monthly. In UNICEF assisted zones about 103(81%) of woredas and 524 (77%) of health centers were supported to conduct EVM self-assessment using 24 and 25 item checklists. Among the woredas conducted self- assessment 61% of woredas and 67.4% of health centers scored 80% and above. During the reporting period, no stock out and overstock of antigens were reported from the woredas and health facilities that conducted self-assessment. UNICEF staff also supported six EPSA hubs on the implementation of EVMA improvement plan.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted EVMA self-assessment in 85% of EPSA centre and hubs and 80% of districts at the 14 UNICEF supported zones, EVM Improvement plan developed; and attain EVM indicator for temperature (E2) at least 80% in 85% of the targets once in a year.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Cold chain and vaccine management focal persons? self-assessment on effective vaccine management (EVM) was demonstrated to improve the effective vaccine and cold chain management in pharmaceutical supply agency (PSA) hubs. The self-assessment initiative was also rolled out to woreda health office cold rooms and health centers. The self-assessment initiative was implemented in 89 woredas in UNICEF supported Zones through support from UNICEF ECO and technical assistance. Woreda and health facilities vaccine management focal persons were provided tools with 24 to 25 item questions and orientations to conduct EVM self-assessment. Through follow-up and supervision woreda cold chain store and health center effective vaccine management score improved from 51% (baseline) to 63% for woredas and HC, 52% to 67% for health centers within four to six months. Such initiative is important on the maintain the potency of vaccines at service delivery level and will continue to reach at least 80% standard. The the baseline for self-assessment was the 2019 national EVMA assessment at woreda and service delivery level.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Triangulatation conducted on vaccine stock and performance, administrataive data validated and feedback provided quarterly in 80% of woredas in 14 UNICEF supported zones in Amhara, Oromia and SNNP Regions.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Data triangulation and taking remedial action is critical in areas where inflated administrative coverage data are reported. Immunization data from small scale surveys and administrative data was reviewed from facility catchment. Feedbacks from both data sources provided for respective health managers. In most areas administrative coverage is higher than survey data. However, the discrepancy is not as high as in large scale surveys. With support from UNICEF TAs small scale local surveys are conducted to verify dropouts and zero-dose children in specific health capacity catchment where 100+ coverage is reported. During the last six months, data quality verification was conducted in 106 health facilities particularly at health post level in 78 woredas. The verification was made by dividing recounted from source document by reported number. Those reported figure from 90 to 110% are considered as normal. While those reported below 90% considered as over reporting and greater than 110% were considered as under reporting. About 67% health posts reported within acceptable range while about one third over or under reported. Many health posts tend to over report and over reporting increases for later doses such as MCV1 and MCV2 this is almost similar across the health facilities. For example, about 30(29%) and 11 (10%) health posts had over and under reported respectively. Similarly, for MCV2 46(43%) and 10(9%) health posts over and under reported respectively. The reason for over and under reporting might be due to lack of source document at health posts and to align with plans. Feedbacks are provided for respective health facilities and health managers. Data triangulation with vaccine issued is undergoing through UNICEF support in collaboration with EPSA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Triangulatation conducted on vaccine stock and performance, administrataive data validated and feedback provided quarterly in 80% of woredas in 14 UNICEF supported zones in Amhara, Oromia and SNNP Regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Data triangulation for vaccine distributed and doses given was conducted by desk review through UNICEF support. Four years data (Ethiopian budget year 2009, 2010, 2011 and 2012) doses given from HMIS and doses distributed from LMIS was analyzed. Besides survey data mDHS data was analyzed for the corresponding Ethiopia budget year. The analysis was made for three antigens (Pentavalent, PCV and Rota vaccines). The analysis was conducted for 828 woreda health offices for HMIS and LMIS data. Almost in all regions, HMIS data reported overage compared to LMIS where the reverse was supposed to be true. Among regions Tigray and Benishangul Gumez had relatively better data consistency while Oromia data was the most inconsistent. When mini Demographic and health data was equated with LMIS and HMIS, the DHS data showed the lowest across the analyzed years. This means the number of estimated doses given are lower than the number of doses distributed during matching year which is more likely to happen. Few woredas data was within acceptable range between distributed doses and reported through DHIS2. The findings of data triangulation with presented to PSA and EPI managers at national and sub-national level. Actions was drawn to improve data quality particularly DHIS2 reporting. UNICEF is reporting monthly vaccine stock status (at national and sub national level) improving the data visibility and reporting trends for ESARO</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CCE inventory performed/updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CCE inventory data regularlly updated and rehabilitation plan developed/implemented for 85% of the national &amp; subnational (EPSA centre &amp; hubs) and 80% districts at 14 Unicef supported zones in three regions, quarterly. (Comment: Can make it clear and the CCEI is done recently by MoH and what is the importance of it)[Response:1.  Review CCEOP-ODP implementation /follow up the installation /commissioning and update the CCEI 
2. Rehabilitation ? follow up new CCE deployment and maintenance of the existing equipment progress  ]">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">EPHI through UNICEF and National Logistic Technical Working Group (NLTWG) conducted cold chain inventory in 2019/2020. The draft report was submitted to MoH. The NLTWG reviewed and provided comments on the missed data elements, such as equipment age, model, miss match between model and manufacturer, equipment types etc. The draft report and raw data is now available and used to update the cMYP and used for CCEOP proposals and deployment plan. EPHI is expected to submit the updated report after addressing comments. While the national level inventory data provides overall cold chain status for the country, it has little importance for local level decision making. Local (woreda) level periodic inventory and listing provides information on cold chain status such as functionality to take timely actions. UNICEF consultants with woreda health office and zonal health EPI and cold chain technician conducted simple inventory mainly functionality of refrigerators and types in UNICEF supported zones. Non-functional refrigerators were identified and listed by woreda. Accordingly, the non-functional refrigerators were identified and listed for maintenance purpose. For example, Amhara Regional Health Bureau with technical and financial support from UNICEF and CHAI, trained about 126 woreda and health facility cold chain technicians on cold chain maintenance. As part of the practical training, four Zones organized refrigerator maintenance campaign and maintained 192 non-functional refrigerators which helped to reduce session interruption and improved access to vaccination service. 
The CCI data is now uploaded in the web based data base.. Once the content of the data is reviewed and endorsed by the NLTWG, access will be provided for the respective regions (including for those UNICEF supported regions and zones).
The final and official report is expected from EPHI with in the coming days and it will be shared for all stakeholders.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CCE inventory data regularlly updated and rehabilitation plan developed/implemented for 85% of the national &amp; subnational (EPSA centre &amp; hubs) and 80% districts at 14 Unicef supported zones in three regions, quarterly. (Comment: Can make it clear and the CCEI is done recently by MoH and what is the importance of it)[Response:1.  Review CCEOP-ODP implementation /follow up the installation /commissioning and update the CCEI 
2. Rehabilitation ? follow up new CCE deployment and maintenance of the existing equipment progress  ]">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Following the 2019 CCE inventory result, in UNICEF supported 12 zones UNICEF deployed consultants identified functional and non-functional refrigerators prepared maintenance plans. Accordingly, 177 technicians trained user level maintenance and maintained a total of 62 refrigerators as part of practical training. GAVI CCEOP Year 2 and 3 with a total of 2562 refrigerators will be installed by two Local service agents: Vest Frost and Bmedical Company. These suppliers did Central and regional level trainings. UNICEF supported Regional Health Bureaus to submit verified ODPs and currently installation is ongoing. As thus far, Bmedical installed 90 SDDs of 359 allocated equipment?s (25%). Vest Frost installed 170 SDDs of 2203 allocated equipment?s (8%). UNICEF through its field offices and consultants is facilitating the installation of SDDs. As part of the effort to strengthen the cold chain system, UNICEF is supporting the procurement of CCEs through various grant sources. With the COVAX CCEs support, a total of 430 ILRs, 59 freezers, 9 WICRs, 3 combined WICRs/FRs, 10,600 vaccine carriers and 1470 cold boxes are on pipeline. CCE support through the GoJ consisting 18 SDDs, 70ILRs, 50 freezers, 2 combo WICRs/FRs, 1150 vaccine carriers and 150 cold boxes are under procurement process and part of the shipment is on transit. UNICEF CO is also facilitating the procurement of additional CCEs mainly to capacitate the service delivery points with funding source form the world bank, totaled 31mUSD. ODP is developed and the PMT is working to finalize and initiate the procurement process.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Remote data collection platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor stock data and provide feedback for 85% of districts in the 14 UNICEF supported zones who are using mBrana quarterly. (Comment: is that supervision or feedback) - [Respon. mBrana data accessed remotely, analyzed and feedback provided to assessed districts. Supervision and workshop will be conducted to enhance and reinforce mBrana utilization.]">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The piloted mBrana system used to monitor stock data was interrupted following the shifting of ownership from partner who used to support to Government system. Recently, the Digitalizing Health activity Project (DHA) is working with EPI and IT team to recommence the system. UNICEF consultant hired by GAVI TCA is a focal person who follow revitalization stock monitoring. Advocacy meeting will be held with decision makers among key stakeholders for ownership and sustainability.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor stock data and provide feedback for 85% of districts in the 14 UNICEF supported zones who are using mBrana quarterly. (Comment: is that supervision or feedback) - [Respon. mBrana data accessed remotely, analyzed and feedback provided to assessed districts. Supervision and workshop will be conducted to enhance and reinforce mBrana utilization.]">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The piloted mBrana system used to monitor stock data was interrupted following the shifting of ownership from partner who used to support to Government system. Recently, the Digitalizing Health activity Project (DHA) is working with EPI and IT team to recommence the system. UNICEF consultant hired by GAVI TCA is a focal person who follow revitalization stock monitoring. Advocacy meeting will be held with decision makers among key stakeholders for ownership and sustainability.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor stock data and provide feedback for 85% of districts in the 14 UNICEF supported zones who are using mBrana quarterly. (Comment: is that supervision or feedback) - [Respon. mBrana data accessed remotely, analyzed and feedback provided to assessed districts. Supervision and workshop will be conducted to enhance and reinforce mBrana utilization.]">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to competing priorities including COVID-19 vaccination micro-planning, vaccine distribution and vaccination rollout. EPSA with MoH and partners is working to rollout vaccine visibility in lower level. There is a high level discussion to revitalize mBrana as its utilization has already been affected due to the interruption of support (financial dand technical) from JSI. Sub working group is established to work with the team and resume mBrana utilization at all districts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report on study findings; Materials pilot tested and status reported; recommendations on approaches aimed at increasing awareness and demand for MCV2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the planned introduction of MCV2 in Ethiopia in 2018, operations research to identify and mitigate barriers to uptake of second year of life (2YL) services (e.g. MCV2), and recording/reporting of vaccines doses delivered in 2YL; development and roll-out of training materials for 2YL, with emphasis on use of MCV2 as an opportunity to catch-up children on vaccinations that were missed during the first year of life; communications messaging to increase awareness and demand for MCV2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The MCV2 barriers assessment has completed all the field work and the study findings are currently being compiled into a final report. There are two sections to the work that are currently undergoing analysis: a) the quantitative survey across 18 districts of healthcare workers, caregivers and EPI focal persons in the Region (in total &gt;1,600 individuals were interviewed), and b) a series of detailed qualitative focus group discussions (&gt;80), and in-depth interviews (&gt; 40) with healthcare workers, caregivers, EPI focals and community leaders across 10 districts. Both will be combined for one overall comprehensive report on the barriers to MCV2 across the Oromia Region. Increasing the awareness on the demand for MCV2 is complete through radio messaging in the local language across the Region, and also ongoing demand generation activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Continuation of implementation period, and reporting on status</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described int he literature. CDC has been working with Ethiopia MoH and WHO to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial. IRB approval has already been optained and baseline data collection began in Q4 2018. We propose to implement 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2019-2020. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The measles 5 dose study reached 6 months of Randomized Controlled Trial implementation mid-June 2021. Implementation update reports are available, and a full mid-term assessment of where we are in terms of the field activities is being planned for July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initiate study, and report status; draft materials developed for catch-up vaccination in line with MCV2 introduction; assessment of impact of current messaging</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the planned introduction of MCV2 in Ethiopia in 2018, operations research to identify and mitigate barriers to uptake of second year of life (2YL) services (e.g. MCV2), and recording/reporting of vaccines doses delivered in 2YL; development and">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The study completed the field work, and the analysis and write up is ongoing. Supportive supervision and enhanced strategies for catch-up of MCV2 is being provided across the Region. Additional MCV2 messaging has rolled out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training conducted; 16 month implementation phase initiated in selected zones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described int he literature. CDC has been working with Ethiopia MoH and WHO to design and implement a randomized control study to document and measu">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Training and health care worker orientation is complete and 6 months of implementation is now complete, and on track to carry out the remaining implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Risk communication strategy developed and implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for risk communication strategy cascade">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">PATH received the first draft on June 7. By the end of June, the final documents will be approved.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual EPI program review meeting conducted in Afar and Somali regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct regional data driven annual EPI program review in Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Not done in Afar region due to the current conflict in the region</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct regional data driven annual EPI program review in Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Planned for July 2021 to align with Government plan</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct regional data driven annual EPI program review in Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Planned for July 2021 to align with Government plan</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Post covid 19 strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Developing action plans for covid exit strategy">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Suspended due to the COVID 19 pandemic. Country still facing COVID 19, so its too early to plan for COVID exit strategy. Activity funded under the NCE ended in May 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Capacity built</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct training on COVID prevention mechanisms, on mainitaining RI during the pandemic">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Training completed by the end of June.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in national M&amp;E technical working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national data quality improvement plan, program quality with participation in national M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national data quality improvement plan, program quality with participation in national M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in regional M&amp;E technical working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional data quality improvement plan, program quality with participation in regional M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional data quality improvement plan, program quality with participation in regional M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">DQS conducted in all project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Data Quality Self-assessment (DQS) in 8 project woredas of Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Data Quality Self-assessment (DQS) in 8 project woredas of Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. One round onsite mentoring provided for Afar and Somali RHBs and 8 project woreda health offices</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Afar and Somali RHBs and 8 project woreda health office EPI team assisted in designing EPI specific dashboard</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Two Regional community engagement strategies for high risk communties available for SNNP and Oromia</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake Key activities 1 Develop and implement tailored behavior and social changes strategy for remote rural, urban scattered communities , conflict affected and communities with low socio-economic status and implementation in 14 zones in Amhara Oromia and SNNPR 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC 3. Strengthen SBCC coordination at regional level and in 14 UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 4. Support MCV2 , Measles SIA and NVI roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF ECO has been applying Human Centered Design thinking approach (HCD) for the development of tailored demand interventions in Oromia and SNNP regions. By the reporting period, rapid inquiries have been conducted with participation of Regional Health Bureau, health workers, caregivers and community members in Oromia and SNNP regions. It is planned to proceed further interventions in reaching children in peri-urban community of Oromia and rural-poor community of SNNP by using HCD approach.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In-depth assessment of data quality (DQR, DQA, audit) performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint quarterly visits to regions to evaluate data validation and data triangulation systems focusing in the four big region">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Because of shortage of budget the activities was not conducted in the reporting period however JRF data and immunization coverage estimate prepared and submitted to AFRO.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint quarterly visits to regions to evaluate data validation and data triangulation systems focusing in the four big region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has prepared a protocol and supervisory check list for the joint Supportive supervision. The joint assessment visit which WHO is part of the assessment group deployed more than 10 staffs and conducted for 15 days in all regions, including in 8 GAVI priority zones helped to evaluate data validation and data triangulation system.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has facilitated Data Quality Self assessment (DQS) training for 80 health workers in 2 zones of Oromia regions for 3 days, that can help health workers to assess immunization data for timeliness of reporting , consistency across the board and data quality to use for planning and decision making process</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has facilitated Data Quality Self assessment (DQS) training for 80 health workers in 2 zones of Oromia regions for 3 days, that can help health workers to assess immunization data for timeliness of reporting , consistency across the board and data quality to use for planning and decision making process</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Because of the delay of the 2021 funds, the balance of 25% was used for staff cost. The activities can be conducted when fund is available</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">The planned DQS training could no be conducted due to lack of fund for the activities. It was redirected to staff cost. The planned training will be conducted as the funds recoves from the 2021 GAVI TCA</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has facilitated Data Quality Self assessment (DQS) training for 80 health workers in 2 zones of Oromia regions for 3 days that can help health workers to assess immunization data for timeliness reporting , consistency across the board and data quality to use for planning and decision making process</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has facilitated Data Quality Self assessment (DQS) training for 80 health workers in 2 zones of Oromia regions for 3 days, that can help health workers to assess immunization data for timeliness of reporting , consistency across the board and data quality to use for planning and decision making process</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint quarterly visits to regions to evaluate data validation and data triangulation systems focusing in the four big region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has prepared a protocol and supervisory check list for the joint Supportive supervision. WHO deployed more than 10 officers for the assessment for 15 days in all regions, The assessment finding helped to evaluate immunization data validation and data triangulation system in GAVI priority zones.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Could no be conducted due to lack of fund as a result in delay of the 2021 GAVI TCA funds</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO supported technically FMOH and other partners who are working on immunization data to estimate the national and subnational immunization coverage using data triangulation guideline</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO technically supported FMOH , to estimate the national and subnational immunization coverage using data triangulation guideline</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support NVI, PIRI, multiantigen catch-up campaigns as requested by FMoH and RHBs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to implement: ? 
 ? PIRI in the targeted zones 
 ? AVW
 ? New vaccine introduction (IPV2, COVID-19 vaccine, nOPV2, Yellow fever, MRV and MenAfric A)
 ? SIA
 ? Roll out of C-19 and HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">. Provide technical support to implement: ? 
?	PIRI in the targeted zones: Technical support planned to conduct PIRI in selected GAVI priority zones was not conducted in 2020 due to COVID-19 Pandemic ? 
?	AVW: It was not conducted in 2020 because of the same reasons for PIRI, However, the 2021 AVW was supported from the 2020 TCA plan. Defaulter tracing and vaccination going on in 4 of Gavi priority zones, of Amhara and Oromia region which enables the country to reduce number of children missed their scheduled vaccination. 
?	Roll out of MCV2 to all health facilities: MCV2 is rolled out in more than 90% of the health facilities in the country. Enables the country to increase population immunity and reduce Measles outbreaks We supported during the training and supervision of health care facilities. 
?	HPV vaccinations: Ethiopia has conducted an integrated HPV vaccination for 2019 and 2020 cohort, in and out of school-girls of age 14 years. The 2019 cohort, second round HPV vaccination could not be conducted due to COVID pandemic. The second dose HPV vaccination of 2019 cohort and first round HPV vaccination of 2020 cohort conducted in January 2021 . WHO recruited 9 technical assistance and supported 4 GAVI priority regions and two city administrations. the deployment of the consultants contributed for success full HPV vaccination. As a result, 81.5% of girls age 14 years of 2019 cohort vaccinated for second dose. and 91.5% of girls age 14 years of 2020 cohort vaccinated for first dose</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">prepare concept notes, proposals and workplan, assess readiness and monitor implementation and post implementation of the exercises</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to implement: ? 
 ? PIRI in the targeted zones 
 ? AVW
 ? New vaccine introduction (IPV2, COVID-19 vaccine, nOPV2, Yellow fever, MRV and MenAfric A)
 ? SIA
 ? Roll out of C-19 and HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">WHO has provided technical support which includes supportive supervision and monitoring of the implementation of PIRI activities in the 8 GAVI priority zones of 4 big regions (Amhara,SNNPR,Oromia and Tigray regions).IPV2 switch Concept note prepared and shared with immunization partners. Yellow fever risk assessment survey preparation continued with help of Global EYE secretariat. Measles follow up SIA proposal submitted and approved by GAVI IRC . The country is continuing preparation for November 2021 HPV vaccination and budget provided to Amhara region 2021 AVW</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Health workers in the selected zones will support the effort to identify &apos;0&apos;dose children &amp; unreached communities in their catchment areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize a two days advocacy workshops both at national and regional levels, in the four regions to identify &apos;0&quot; dose children, missed communities and identify priority zones for support: Participants are from Regional MCH, EPI experts from Zones and woredas: drafts a micro planning and work plan to reach the missed communities.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">West Showa and ARSI zones of Oromia and South Gondar and AWI zones of Amhara region completed their preparation to conduct advocacy workshop integrated with review that can help to document lesson learned and identify zero dose children and missed communities for immunization</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Advocacy (review) workshops will be conducted at the four regions involving the selected zones to aware them about the interventions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize a two days advocacy workshops both at national and regional levels, in the four regions to identify &apos;0&quot; dose children, missed communities and identify priority zones for support: Participants are from Regional MCH, EPI experts from Zones and woredas: drafts a micro planning and work plan to reach the missed communities.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Develop concept notes and proposals and share with FMoH for endorsement</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct MOV assessment in selected zones to determine the magnitude and reasons of MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Due to budget shortage post ponded</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">conduct MOV assessment in the selected zones to determine factors contributing to the missed children and community</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct MOV assessment in selected zones to determine the magnitude and reasons of MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">MOV assessment reprogramed for the 2021 GAVI TCA due to other government priorities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI causality assessments conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support biannual meeting of national AEFI committees and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Technical and financial support provided to investigate and classify 5 serious AEFI cases post COVID vaccination</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support biannual meeting of national AEFI committees and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Two TAs recruited to provide technical support for EFDA and EPHI, contributed for successful coordination of these two institutions. Technical Support provided to coordinate national AEFI committees and stakeholders meeting to investigate 9 serious AEFI after COVID vaccination. Regular AEFI committee zoom meeting undergoing to see the progress made</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&gt;80% Health facilities (health posts) in the targeted zones and urban slums developed session plans and vaccine requirements and monitor the conduct of sessions (Micro-planning)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Support training of health workers on the MLM, Combined RED/IIP  focusing on (2YL) to  new 8 priority zones in four big regions (Tigray, Amhara, Oromia, and SNNPR) and health workers health workers from Health facilities with underserved catchment areas in Addis Ababa and Diredawa City Administrations (urban inequalities)">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">West Showa and ARSI zones of Oromia conducted IIP training for 207 health workers with the aim to improve the skill and knowledge of immunization officers, to build their capacity and enable them to provide quality immunization services. South Gondar and AWI zones of Amhara region have completed their preparation to conduct RED and IIP training for health. The remaining two zones of SNNPR and one zone of Tigray regions developed plan and submitted to WHO but because of the delay in the releasing of 2021 GAVI TCA funds implementation IIP training in these 3 zones will not be conducted in the reporting period. The trainings will be conducted when the funds used for staffs recovered from the 2121 GAVI TCA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Support training of health workers on the MLM, Combined RED/IIP  focusing on (2YL) to  new 8 priority zones in four big regions (Tigray, Amhara, Oromia, and SNNPR) and health workers health workers from Health facilities with underserved catchment areas in Addis Ababa and Diredawa City Administrations (urban inequalities)">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">West Showa and ARSI zones of Oromia conducted IIP training for 207 health workers with the aim to improve the skill and knowledge of immunization officers, to build their capacity and enable them to provide quality immunization services. South Gondar and AWI zones of Amhara region have completed their preparation to conduct RED and IIP training for health. The remaining two zones of SNNPR and one zone of Tigray regions developed plan and submitted to WHO but because of the delay in the releasing of 2021 GAVI TCA funds implementation IIP training in these 3 zones will not be conducted in the reporting period. The trainings will be conducted when the funds used for staffs recovered from the 2121 GAVI TCA.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Acasus : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Sustainability plan for the intervention</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Completed and submitted</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Completed and submitted</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Results and analysis from the second household survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Given the MoPH decision to not go ahead with the survey, it was agreed to substitute this milestone with another, on Geo-spatial analysis to identify potential communities home to zero-dose children</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Given the MoPH&apos;s decision to not go ahead with the survey, it was agreed to substitute this milestone with another, on Geo-spatial analysis to identify potential communities home to zero-dose children</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementation plan for the second household survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Government has decided not to progress with a coverage survey, due to the impact of COVID-19 and efforts to rollout COVAX, ongoing conflict, and elections timings. As agreed with Ethiopia SCM, the approach of this document was changed accordingly.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Government has decided not to progress with a coverage survey, due to the impact of COVID-19 and efforts to rollout COVAX, ongoing conflict, and elections timings. As agreed with Ethiopia SCM, the approach of this document was changed accordingly.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">December 2020: Presentations from National and Regional stocktakes (three regions)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Stocktakes from FMoH and each region attached</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Stocktakes from FMoH and each region attached</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report from the project</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Completed</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finalised plan for the scale-up in the Amhara region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Launch the program across the Amhara region from Sept 2021">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Description of results from light support to other regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Completed and submitted</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Presentations from National and Regional stocktakes (three regions)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Completed and submitted</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Update note on activities completed in
the last 2 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Completed and submitted</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Analysis of remaining gaps in immunization activity and availability of critical inputs in target regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">December 2020: Quarterly progress report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">March 2021: Quarterly progress report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regional level advocacy organized in Afar and Somali regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize higher level regional advocacy on immunization for Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Factsheet, brochure, banner, T-shirt and cape designed with necessary key messages in collaboration with FMoH and printed, however the advocacy was not conducted due to current situation in Ethiopia</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize higher level regional advocacy on immunization for Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">This activity might need reprogramming</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize higher level regional advocacy on immunization for Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">This activity might need reprogramming</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IPC training materials developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions - Developed tailored training materials - Provided IPC training for vaccinators - Evaluated impact of the training - Develop comprehensive EPI checklist together with regional and woreda EPI team - Conduct supportive supervision using checklist - Provide onsite and written feedback - Identify and register unreached children under 2 years of age and pregnant women and register - Support PIRI implementation to vaccinate identified targets - Support monitoring of PIRI implementation status - Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes - Support development of RED microplanning - Support monitoring of RED micro-plan utilization - Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">This is 202 milestone now</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supported the planning and organization of 2021 AVW</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2021 AVW planning and implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">we might need to reprogram this activity</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2021 AVW planning and implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">we might need to reprogram this activity</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2021 AVW planning and implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in national communication working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national communication plan with participation in national CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national communication plan with participation in national CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in regional communication working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional communication plan with participation in regional CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional communication plan with participation in regional CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Orientation workshop for public relation officers and media professionals provided in Afar and Somali regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize orientation workshop on immunization for public relation officers and media professionals in Afar and Somali regions  
- Identify local media professionals and public relation officers 
- Prepare training materials  
- Provide orientation for identified participants">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize orientation workshop on immunization for public relation officers and media professionals in Afar and Somali regions  
- Identify local media professionals and public relation officers 
- Prepare training materials  
- Provide orientation for identified participants">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. IPC training provided for 80 participants from 8 project woreds</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Softcopy of translated materials provided to RHBs, woreda health offices and health facilities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support translation of IPC materials - Translate national IPC material in to Afar and Somali languages - Provide softcopy of translated materials to RHBs, Woreda health offices and health facilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. IPC training impact evaluated in 4 project woredas (2 from each region)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions - Developed tailored training materials - Provided IPC training for vaccinators - Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted review meetings with religious leaders for 30 PP</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct  Review meeting on  EPI religious mainstreaming at woreda levels of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct  Review meeting on  EPI religious mainstreaming at woreda levels of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Monitor and evaluate the states of EPI data completeness and timeliness and increase by 40% from the baseline. Monitor and evaluate the states of EPI data and increase by 50% from the baseline. Monitor and evaluate the availability of monthly report and increase to 100% from the baseline.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Routine data quality self-assessment in 8 woredas and 32 HFs twice a year in collaboration with Afar and Somali Regional Bureaus.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Routine data quality self-assessment in 8 woredas and 32 HFs twice a year in collaboration with Afar and Somali Regional Bureaus.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted 96 immunisation community Conversation (CC) cession in selected low coverage kebeles of Afar &amp; Somali region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunisation at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/ Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunisation at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/ Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted joint supportive supervision and follow up</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with CGPP secretariat, PIPs and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with CGPP secretariat, PIPs and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted immunisation advocacy meeting in two zonal of Afar region.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two days immunisation advocacy meeting at zonal level with political, clan and religious leaders of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two days immunisation advocacy meeting at zonal level with political, clan and religious leaders of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Organized Mid and annual review meeting</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize Mid and annual review meeting with the project implementing partners and government staffs from each implementing region, zone and wordas to implementation progress, experience shirring and understand common cosines on the project activity.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize Mid and annual review meeting with the project implementing partners and government staffs from each implementing region, zone and wordas to implementation progress, experience shirring and understand common cosines on the project activity.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize Mid and annual review meeting with the project implementing partners and government staffs from each implementing region, zone and wordas to implementation progress, experience shirring and understand common cosines on the project activity.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 woredas, 10 HCs and 20 HP to be visited for the improved data management and utilisation for decision making at health facility and woreda health office</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide monthly data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide monthly data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted three JSS/ISS on technical support on jobs and monitoring the states of demand and data quality activity</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with PIPs filed officers and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with PIPs filed officers and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">supported two EPI review meetings at woreda level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize and support quarterly  EPI review meetings at woreda level  with the aim of identifying gaps and proposing local solution with the involvement of HEWs/HWs, woreda health offices, partners and members of woreda level EPI task force.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize and support quarterly  EPI review meetings at woreda level  with the aim of identifying gaps and proposing local solution with the involvement of HEWs/HWs, woreda health offices, partners and members of woreda level EPI task force.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 woredas, 10 HCs and 20 HP to be visited for the improved data management and utilization for decision making at health facility and woreda health office</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide Monthly routine data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide Monthly  routine data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali  regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide Monthly  routine data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali  regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. One round supportive supervision conducted to health facilities and woreda health offices using checklist in all project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Onsite and written feedback provided to all project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Comprehensive EPI checklist developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions - Develop comprehensive EPI checklist together with regional and woreda EPI team - Conduct supportive supervision using checklist - Provide onsite and written feedback - Identify and register unreached children under 2 years of age and pregnant women and register - Support PIRI implementation to vaccinate identified targets - Support monitoring of PIRI implementation status - Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes - Support development of RED microplanning - Support monitoring of RED micro-plan utilization - Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.Implementation of monthly session plan monitored monthly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Plan versus achievement monitored on quarterly basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. 80% of the project woredas revised their RED micro-plan bi-annually</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of unreached children and pregnant women vaccinated in 8 project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning and implementation of PIRI in 8 project woredas of Afar and Somali regions  
- Identify and register unreached children under 2 years of age and pregnant women and register  
- Support PIRI implementation to vaccinate identified targets 
- Support monitoring of PIRI implementation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning and implementation of PIRI in 8 project woredas of Afar and Somali regions  
- Identify and register unreached children under 2 years of age and pregnant women and register  
- Support PIRI implementation to vaccinate identified targets 
- Support monitoring of PIRI implementation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 15 meetings held as per work plan and recommendations followed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support woreda EPI task force for local committee composed of Woreda Administration, Woreda Health Officer, Women and Children Affairs Officer, Religious and Clan Leaders, Immunization Partners and other relevant stake holders to monitor and evaluate the EPI program in 8 woredas of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60 percent of Micro planned activities implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technically support and facilitate bottom up and doable RED/C micro planning at woreda level with the involvement of HEWs and Kebele administration and community representatives in 8 woredas and 80 percent of Micro planned activities implementation of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted 90 immunization community Conversation (CC) cession  in   selected low coverage kebeles  of Afar &amp; Somali region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunization at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunization at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted final project assessment and evaluation survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Final project assessment and evaluation survey using WHO 30X10 cluster sampling method of data quality and demand generation in 8 woredas of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Final project assessment and evaluation survey using WHO 30X10 cluster sampling method of data quality and demand generation in 8 woredas of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Final project assessment and evaluation survey using WHO 30X10 cluster sampling method of data quality and demand generation in 8 woredas of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provided refresher training for community conversation facilitation in 30 low preforming kebeles (30 HEWs trained) of Afar &amp; Somali region.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide refresher training for HEWs/ HWs on community conversation facilitation in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supported woreda EPI task force for the  first two quarters in 8 woredas.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support woreda EPI task force for local committee composed of Woreda Administration, Woreda Health Office, Women and Children Affair, Religious and Clan Leaders, Immunization Partners and other relevant stake holders to monitor and evaluate the EPI program in 8 woredas of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support woreda EPI task force for local committee composed of Woreda Administration, Woreda Health Office, Women and Children Affair, Religious and Clan Leaders, Immunization Partners and other relevant stake holders to monitor and evaluate the EPI program in 8 woredas of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted 30 immunization community Conversation (CC) cession in selected low coverage kebeles of Afar &amp; Somali region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunization at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/Caretakers on monthly bases in selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual review meeting held</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen Congenital Rubella Syndrome (CRS) Surveillance">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
      <comment>
       <narrative xml:lang="EN">Major delays. Multiple outbreaks delayed implementation, discussions in country to move forward.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">completed readiness assessment from at least 2 sub-districts and/or 2 districts; completed independent monitoring forms/analysis from at least 5 vaccination sites; completed RCM in at least 5 catchment areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1 CDC staff to provide TA for 30 days to ensure high quality preparation, implementation and monitoring for measles follow up SIA planned in QTR 4 2019">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
